Latest Market News

Diatreme Resources confirms its Northern Silica Project can produce low-iron, high-purity silica sand meeting photovoltaic glass standards, backed by successful bulk metallurgical testwork. The results pave the way for final engineering and commercial deals amid a booming solar energy market.

Artrya Limited has raised A$75 million through a two-tranche placement and launched a A$5 million share purchase plan to fast-track the U.S. commercialisation of its AI-powered Salix platform following FDA clearance.

Computershare Limited has announced an ordinary dividend of AUD 0.48 per share for the half-year ending June 2025, alongside a confirmed Dividend Reinvestment Plan price of AUD 37.64.

Snow Lake Energy has completed its strategic investment in American Uranium Limited, acquiring a 9.9% stake and board representation, strengthening ties between adjacent uranium projects in Wyoming amid a U.S. nuclear energy resurgence.

Trading in Jindalee Lithium Limited shares has resumed following the company’s announcement of a potential merger, signaling a pivotal moment for the lithium miner.

Jindalee Lithium has signed a non-binding LOI to merge its US lithium assets with a US SPAC, aiming to list on a national exchange and unlock significant funding for its McDermitt Project.

Proteomics International Laboratories announces the planned retirement of its founder and Managing Director, Dr Richard Lipscombe, in February 2026, marking a pivotal leadership transition as the company seeks a new CEO to drive its next growth phase.

Euro Manganese Inc. reports significant progress on its Chvaletice Project and Bécancour Plant, positioning itself as a key Western supplier of high-purity manganese critical for EV batteries. The company highlights strong feasibility results, strategic financing partnerships, and multiple offtake agreements amid an expected global supply deficit.

Gladiator Resources is in talks with multiple parties to sell its Tanzanian uranium assets, aiming to strengthen its balance sheet and pivot towards U.S.-based rare earth projects.

Telix Pharmaceuticals has secured FDA agreement on a resubmission plan for its glioma imaging agent TLX101-CDx, aiming for a Q4 2025 filing that includes additional efficacy data. The FDA signals likely expedited review, underscoring the unmet medical need.

Livium Ltd has inked a term sheet with the University of Melbourne to exclusively commercialise innovative microwave technology for rare earth elements extraction, promising high recovery rates and major energy savings.

Polymetals Resources reports steady operational gains at its Endeavor silver-zinc mine, hitting key production and financial milestones including a scheduled first zinc concentrate shipment and inclusion in the ASX All Ordinaries Index.